EUVIMEDEUVIMED entdecken
Open Access

JAK Inhibitor Tofacitinib Ameliorates Inflammation Response and Osteogenic Differentiation in Immune‐Mediated Inflammatory Arthritis in Rats

Zhiming Zhang, Zhiming Lin, Genlian Hu, Qingqing Huang, Congrong Xu, Jiafang Zhang, Fangzhen Wu, Rongbin Song, Hongshan Chen, Feng Zheng iD

International Journal of Rheumatic Diseases · 2026-07 · 29 (7)

DOI: 10.1111/1756-185x.70773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 15.07.2026. Verfasst von Zhiming Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The Second Affiliated Hospital of Fujian Traditional Chinese Medical University, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Osteogenesis, Piperidines, Pyrimidines, Arthritis, Experimental. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fujian Provincial Education Research Project for Young and Middle-aged Teachers (Science and Technology), Fujian Provincial Natural Science Foundation Project, Guangzhou Science and Technology Program Key Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study sought to investigate the mechanism by which tofacitinib affects inflammatory response and osteogenic differentiation in immune‐mediated inflammatory arthritis in rats in relation to Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3).

Methods

Wistar male rats were induced by the combination of bovine proteoglycan and incomplete/complete Freund's adjuvant to establish the immune‐mediated inflammatory arthritis model. The clinical manifestations were observed. Hematoxylin and eosin staining was used to evaluate pathological changes in sacroiliac joints and surrounding cartilage. Additionally, the levels of osteogenic differentiation‐related proteins, serum inflammatory factors, and alkaline phosphatase (ALP) were measured. Flow cytometry was conducted to analyze the proportion of Th17 cells in peripheral blood. Alizarin red staining detected the osteogenic differentiation of ligament fibroblasts.

Results

The rats exhibited joint swelling, inflammatory infiltration in the sacroiliac joint, and cartilage destruction after modeling. Elevations were also detected in the levels of serum pro‐inflammatory factors, the proportion of Th17 cells, ALP activity, phosphorylated (p)‐JAK1/2, p‐STAT3, osteogenic differentiation markers in ligament fibroblasts, as well as in the mineralized nodules. Tofacitinib intervention inhibited the phosphorylation of JAK and STAT3, downregulated bone differentiation‐related proteins, decreased the mineralized nodules, reduced the activity of ALP, and decreased the levels of pro‐inflammatory factors. However, the combined use of the STAT3 agonist Colivelin partially reversed the inhibitory effect of tofacitinib on joint inflammation and osteogenic differentiation.

Conclusion

Tofacitinib alleviated the inflammatory response in immune‐mediated inflammatory arthritis and inhibited osteogenic differentiation in rats via inhibition of the JAK/STAT3 signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisPiperidinesPyrimidinesArthritis, ExperimentalCell DifferentiationJanus Kinase InhibitorsAnti-Inflammatory AgentsJanus KinasesSacroiliac JointAnimalsMaleSTAT3 Transcription FactorRats, WistarSignal TransductionTh17 CellsInflammation MediatorsPhosphorylationCytokinesPyrroles

Stichwörter der Autor:innen

JAK/STAT3 signaling pathwayinflammatory disorderinflammatory responseosteogenic differentiationtofacitinib

Substanzen

tofacitinibPiperidinesSTAT3 Transcription FactorPyrimidinesStat3 protein, ratJanus Kinase InhibitorsAnti-Inflammatory AgentsInflammation MediatorsJanus KinasesCytokines

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, The Second Affiliated Hospital of Fujian Traditional Chinese Medical University, Fuzhou, Fujian, China.
  • Department of Rheumatology and Immunology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Department of Preventive Treatment of Disease, The Third People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
  • Department of Rheumatology and Immunology, Sanming Integrated Traditional Chinese and Western Medicine Hospital, Sanming, Fujian, China.
  • Department of Clinical Laboratory Medicine, The Second Affiliated Hospital of Fujian Traditional Chinese Medical University, Fuzhou, Fujian, China.
  • Department of Spinal Surgery, The Second Affiliated Hospital of Fujian Traditional Chinese Medical University, Fuzhou, Fujian, China.

ORCID-Profile: Feng Zheng

Förderung

  • Fujian Provincial Education Research Project for Young and Middle-aged Teachers (Science and Technology)
  • Fujian Provincial Natural Science Foundation Project
  • Guangzhou Science and Technology Program Key Project

Zitieren

APA

Zhang, Z., Lin, Z., Hu, G., Huang, Q., Xu, C., Zhang, J., Wu, F., Song, R., Chen, H., & Zheng, F. (2026). JAK Inhibitor Tofacitinib Ameliorates Inflammation Response and Osteogenic Differentiation in Immune‐Mediated Inflammatory Arthritis in Rats. International Journal of Rheumatic Diseases, 29(7). https://doi.org/10.1111/1756-185x.70773

Vancouver

Zhang Z, Lin Z, Hu G, Huang Q, Xu C, Zhang J, et al. JAK Inhibitor Tofacitinib Ameliorates Inflammation Response and Osteogenic Differentiation in Immune‐Mediated Inflammatory Arthritis in Rats. International Journal of Rheumatic Diseases. 2026;29(7). doi:10.1111/1756-185x.70773

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhiming and Lin, Zhiming and Hu, Genlian and Huang, Qingqing and Xu, Congrong and Zhang, Jiafang and Wu, Fangzhen and Song, Rongbin and Chen, Hongshan and Zheng, Feng},
  title = {JAK Inhibitor Tofacitinib Ameliorates Inflammation Response and Osteogenic Differentiation in Immune‐Mediated Inflammatory Arthritis in Rats},
  journal = {International Journal of Rheumatic Diseases},
  year = {2026},
  volume = {29},
  number = {7},
  doi = {10.1111/1756-185x.70773}
}
Kostenlos starten →